Assessment of ovulation synchronization protocols in goats and use of pregnancy specific protein B (PSPB) enzyme linked immunsorbent assay (ELISA) to determine kid number at birth.

The efficacy of several protocols for ovulation synchronization and timed artificial insemination (TAI) in goats was examined. In addition, the relationship between levels of pregnancy specific protein B (PSPB) during gestation assessed with a commercially available ELISA and the number of offspring at birth was determined. In Experiment 1, 70 does were randomized into four treatments: (1) breed by estrus [BBE], (2) 6-d treatment with a new [C6N], (3) once-used [C61], or (4) twice-used Controled Internal Drug Release (CIDR) device [C62)]. BBE does received two 15 mg doses of prostaglandin-F2α (PGF) at a 10-d interval and were bred 12 h after estrus onset. CIDR groups received a CIDR for 6 d with 15 mg PGF given at CIDR removal. TAI was performed 48 h after CIDR removal and does were given 50 µg GnRH. All does were inseminated with a single dose of frozen semen using a non-surgical, transcervical technique. Pregnancy rates for the BBE, C6N, C61 and C62 treatment groups were 39% ± 12%, 64% ± 12%, 77% ± 12% and 57% ± 12%, respectively, and did not differ. Reuse of CIDRs, even with reuse extending for a total of 21 d, was as effective as new CIDRs for synchronization of ovulation. In Experiment 2, 68 does were randomized into four treatments: (1) BBE, (2) C6N, (3) NC.Synch [NCS], (4) modified NCS [NCSM]. The BBE and C6N groups were as described for Experiment 1. The NCS and NCSM groups received 15 mg PGF on Day 1, 50 µg GnRH on Day 8 and 15 mg PGF on Day 15 (NCS) or Day 15.5 (NCSM). Does were bred by TAI at 72 h (NCS) or 60 h (NCSM) after the second PGF injection. All does in the NCS and NCSM groups received 50 µg GnRH at TAI. Pregnancy rates were 53% ± 12%, 30% ± 11%, 50% ± 11% and 41% ± 12% for does in the BBE, C6N, NCS and NCSM group, respectively, and did not differ. In Experiment 3, 62 does pregnant to TAI were bled at Days 48 and 85 post-insemination for PSPB. Data on kid numbers and birth weights were subsequently recorded. At Day 48 of gestation, PSPB levels for does birthing singletons were lower than for does birthing twins or triplets (25.0 ± 0.1a, 28.8 ± 0.1b and 30.7 ± 0b ng/mL, respectively, abP<0.05). At Day 85 of gestation, PSPB levels were progressively greater for does birthing singletons versus twins versus triplets (27.0 ± 0.1a, 28.5 ± 0.1b and 31.6 ± 0c ng/mL, abcP<0.05). In conclusion, PSPB concentrations detected using a commercially available ELISA at Day 48 or 85 of gestation could distinguish does carrying single versus multiple fetuses.

Influence of multiple reuse and resterilization cycles on the performance of a bipolar vessel sealing device (LigaSure) intended for single use.

OBJECTIVE: To determine the number of use/cleaning/resterilization cycles that can be safely applied to a vessel sealing device intended for single use (LigaSure). STUDY DESIGN: Ex vivo study. SAMPLE POPULATION: LigaSure Small Jaw handsets (n = 6) and LigaSure Impact handsets (n = 6). METHODS: Handsets underwent simulated splenectomy/cleaning/resterilization cycles until failure, defined as leaking vascular seal or blade retraction failure. Functional testing included assessment of vascular seal integrity, handset activation/tissue release, and cutting blade wear/retraction. Vascular seal failure was defined as a leak occurring at <300 mm Hg. Cycles to failure were recorded. Sealed vessels were evaluated by histology at first handset use and failure. RESULTS: Vascular seals created with the Small Jaw handset failed at a mean (95% CI) of 17.2 cycles (9.6-24.8) and a minimum of 10 cycles. Vascular seals created with the Impact failed at a mean of 20 cycles (18.4-21.6) and a minimum of 17 cycles. The majority of seal failures (73%; 95% CI 39%-94%) immediate leaked during vessel filling. The rate of vascular seal failure increased after the initial failure. Failure was associated with histologic disparities in tissue apposition. CONCLUSION: Repeated use and resterilization resulted in failure of the vascular seal due to inadequate tissue apposition after a minimum of 10 cycles. CLINICAL SIGNIFICANCE: Surgeons reusing and resterilizing LigaSure handsets (ForceTriad platform) should consider discarding handsets after 9 cycles for the Small Jaw and after 16 cycles for the Impact. Handsets should be immediately discarded after any intraoperative identification of vascular seal failure.

Follicular dynamics, circulating progesterone, and fertility in Holstein cows synchronized with reused intravaginal progesterone implants that were sanitized by autoclave or chemical disinfection.

This experiment aimed to compare circulating progesterone (P4), follicular dynamics, and fertility during reuse of intravaginal P4 implants that were sanitized by autoclave or chemical disinfection in lactating Holstein cows submitted to fixed-time artificial insemination (FTAI). For this, 123 primiparous and 226 multiparous cows from 2 farms, averaging (mean ± standard deviation) 163.9 ± 141.9 d in milk, 35.7 ± 11.3 kg of milk/d, and a body condition score of 2.9 ± 0.5, were enrolled in the study. Cows were randomly assigned to 1 of 2 treatments using a completely randomized design and each cow received a reused implant (1.9 g of P4; previously used for 8 d) that was either autoclaved (AUT; n = 177) or chemically disinfected (CHEM; n = 172) on d -10. Also on d -10, cows received 2 mg of estradiol benzoate and 100 µg of GnRH. On d -3, cows received 25 mg of dinoprost (PGF2α). A second PGF2α was given on d -2, along with 1 mg of estradiol cypionate and P4 implant removal. Cows received FTAI on d 0. A subset of cows (n = 143) was evaluated by ultrasound on d -10, -8, -6, -3, -2, 0, and 5 to identify ovarian structures, and blood was sampled on d -10, -3, and -2 for P4 concentrations by RIA. Pregnancy diagnoses were performed at d 32 and 60. Statistical analyses was performed using PROC-MIXED for continuous variables and PROC-GLIMMIX of SAS 9.4 (SAS Institute Inc., Cary, NC) for binomial variables. The treatments did not differ in circulating P4 on d -10 or -3, but P4 was greater on d -2 in CHEM cows. Ovulation to the treatments on d -10 was associated with lower circulating P4 on d -10 (2.0 vs. 3.1 ng/mL) and resulted in greater P4 on d -3 (4.0 vs. 2.4 ng/mL) and more cows with a corpus luteum on d -3 (100 vs. 40%) than nonovulating cows. Cows that ovulated to d -10 treatments were more likely to have a synchronized new follicular wave (97.9 vs. 63.2%) and had an earlier wave emergence (1.9 vs. 2.6 d), resulting in less cows ovulating a persistent follicle (0.0 vs. 35.7%). Type of P4 implant, corpus luteum presence on d -10, and ovulation to d -10 treatments did not affect fertility (pregnancy per AI; P/AI). However, P/AI on farm A was greater than on farm B at 32 (40.8 vs. 27.8%) and 60 d (35.8 vs. 24.3%), independent of treatment. In conclusion, P4 implants with different P4 release patterns did not produce detectable differences in follicular dynamics, synchronization rate, or P/AI. Nevertheless, presence of corpus luteum or ovulation at the beginning of the FTAI protocol affected reproductive variables, such as timing and synchronization of follicular wave emergence, and size of the ovulatory follicle. Beyond that, more overall synchronized cows became pregnant to the FTAI protocol.

Reutilização de implante intravaginal de progesterona para sincronização de estro em bovinos / The reuse of intravaginal progesterone implant for estrus synchronization in bovines / Reutilización de implante intravaginal de progesterona pa ra sincronización de estro en bovinos

A inseminação artificial em tempo fixo (IATF) em bovinos, apresenta uma série de vantagens que incluem desde o manejo dos animais a otimização da mão-de-obra. Sua aplicabilidade baseia-se em combinações hormonais capazes de sincronizar o estro e a ovulação, permitindo que a IA seja feita sem a observação da fêmea em estro. Entre os hormônios utilizados para esse fim, o dispositivo a base de progesterona, conhecido também como CIDR (Realeasing Drug Internal Controlled) corresponde ao maior custo, muitas vezes inviabilizando sua utilização, o que justifica a busca por alternativas capazes de ajustar a relação custo/benefício dos protocolos de IATF, por meio da reutilização do CIDR. Nesse contexto, pretende-se com esse estudo, apresentar aspectos relevantes da manifestação de estro, concentração de progesterona, taxa de gestação, relação custo/benefício, bem como dos problemas decorrentes da reutilização de implante intravaginal de progesterona para sincronização de estro em bovinos, sem contudo esgotar a literatura sobre o assunto.

The fixed time artificial insemination (FTAI) in bovines presents a number of advantages that includes since animal management to workforce optimization. Its applicability is based on hormonal combinations capable of synchronizing the estrus and ovulation, allowing the AI free female observation in estrus. Among the hormones used for this purpose, the device based on progesterone, also known as Classless Inter-Domain Routing (Realeasing Drug Internal Controlled) corresponds to the higher cost, often making it unfeasible to use, which justifies the search for alternatives able to adjust the cost/ benefit of FTAI protocols, through the reuse of CIDR. In this context, the purpose of this study submits relevant aspects of the manifestation of estrous, concentration of progesterone, pregnancy rate, cost/benefit as well as the problems of reuse of intravaginal progesterone implant for estrus synchronization in bovines, without exhausting the literature on the subject.

La inseminación artificial en tiempo fijo (IATF) en bovinos, presenta una serie de ventajas que incluyen desde el manejo de los animales a la optimización de la mano de obra. Su aplicabilidad se basa en combinaciones hormonales capaces de sincronizar el estro y la ovulación, permitiendo que la IA sea hecha sin la observación de la hembra en estro. Entre las hormonas utilizadas para ese fin, el dispositivo a base de progesterona, conocido también como CIDR (Realeasing Drug Internal Controlled) corresponde a un costo mayor, muchas veces haciendo con que su utilización se vuelva inviable, lo que justifica la búsqueda por alternativa capaces de ajustar la relación costo/beneficio de los protocolos de IATF, por medio de la reutilización del CIDR. En ese contexto, se pretende con ese estudio, presentar aspectos relevantes de la manifestación de estro, concentración de progesterona, índice de preñez, relación costo/beneficio, bien como los problemas decurrentes de la reutilización de implante intravaginal de progesterona para sincronización de estro en bovinos, pero sin agotar la literatura sobre el asunto.

Ophthalmic surgical instruments.

With proper training and diligent practice, many orbital, extraocular, and corneo-conjunctival surgeries can be successfully performed by the general practitioner. Specialized surgical instrumentation is necessary to achieve optimal results. This article reviews the essential surgical instruments required for these routine ophthalmic surgeries and provides guidelines for suture selection. Recommendations for handling and care of ophthalmic surgical instruments, including cleaning, sterilization, and storage, are provided.

High-pressure steam sterilization of previously used CIDR inserts enhances the magnitude of the acute increase in circulating progesterone after insertion in cows.

Objectives were to compare serum concentrations of progesterone (P4) in ovariectomized cows receiving (1) new, (2) re-used disinfected (DIS), and (3) re-used autoclaved (AC) controlled internal drug release (CIDR) inserts. Five ovariectomized (OVX) beef cows were used in a replicated 3 x 3 Latin square design. Each experimental period was 7 days, with at least 48 h between periods. All re-used CIDR had been inserted previously in beef cows for 7 days. Upon removal, CIDR used for the DIS treatment were washed thoroughly and soaked in a chlorhexidine gluconate solution (0.03%) for 2h, rinsed thoroughly with water and air-dried. For the AC treatment, CIDR were not soaked in disinfectant but were steam sterilized at 121 degrees C and 724 mmHg for 20 min before use. Blood samples were collected at 0, 10, 30, 60, 180, and 480 min relative to time of insertion of CIDR, daily until day 7, and at 30, 60, and 180 min relative to time of removal for radioimmunoassay of P4. Mean serum concentrations (ng/mL) of P4 during the 7-day period of insertion were greater (P<0.03) for new (3.7+/-0.2) and AC (3.4+/-0.3) than for DIS CIDR (2.8+/-0.2). These effects were created primarily by differences occurring during the first 8h after CIDR insertion. Within this interval, mean concentrations (ng/mL) differed (P<0.05) among all groups, but values for AC (6.0+/-0.7) exceeded both new (4.6+/-0.5) and DIS (2.7+/-0.3) markedly. Autoclaving may be the best option when re-using CIDR inserts because it creates greater concentrations of P4 immediately after insertion and reduces maximally the risk of disease transmission.

Fertility in beef cattle given a new or previously used CIDR insert and estradiol, with or without progesterone.

The objective was to compare pregnancy rates following fixed-time AI (FTAI) in beef cattle given a new or previously used CIDR insert and injections of estradiol, with or without progesterone, to synchronize follicular wave emergence. In Experiment 1, heifers (n=616) received a new or once-used CIDR insert for 9 days and were given 1mg estradiol cypionate (ECP), with or without 100 mg of a commercial progesterone preparation (CP4), at CIDR insertion. Heifers were treated with PGF at CIDR removal and 0.5 mg ECP i.m. 24h later, with FTAI 55 to 60 h after CIDR removal. Pregnancy rate was not affected by either the number of CIDR uses (P=0.59; 48.3% versus 46.2% for new versus once-used CIDRs, respectively) or the addition of progesterone (P=0.42; 45.6% versus 48.8% for ECP+CP4 and ECP, respectively). In Experiment 2 (replicated at two locations), heifers (n=56) and lactating beef cows (n=307) received a once- or twice-used CIDR and an i.m. injection of 1mg estradiol benzoate (EB), with or without 100 mg progesterone, at CIDR insertion. Cattle received PGF in the ischiorectal fossa at CIDR removal (Day 7) and 1mg EB i.m. 24h later, with FTAI 52 to 56 h after CIDR removal. Pregnancy rate was affected by location (P<0.002; 46.0% versus 61.1% for Locations A and B, respectively), parity (P<0.04; 67.9% versus 53.1% in heifers and cows, respectively), and numbers of times the CIDR had been used (P<0.03; 62.4% versus 48.4% for once- and twice-used CIDRs, respectively). However, the addition of progesterone to the injection of EB at CIDR insertion did not affect pregnancy rate (P=0.6). In Experiment 3, heifers (n=187) received one new, one once-used, one twice-used or two twice-used CIDRs for 7 days and 2 mg EB plus 50 mg of CP4 at the time of CIDR insertion. Heifers were treated with PGF at CIDR removal and 1mg EB i.m. 24 h later, with FTAI 52-56 h after CIDR removal. Pregnancy rate was not affected by treatments (P=0.28, 57.5, 63.8, 47.9, 47.9% for one new, one once-used, one twice-used, or two twice-used CIDRs, respectively). In summary, pregnancy rate to FTAI did not differ between cattle synchronized with a new or once-used CIDR, but pregnancy rate was lower in cattle synchronized with a twice-used CIDR; however, the insertion of two twice-used CIDRs did not affect pregnancy rates. The addition of an injection of progesterone to the estradiol treatment at CIDR insertion did not enhance pregnancy rate to FTAI.

Maintenance of gastrointestinal endoscopes.

Endoscopes are used for visualization and biopsy of gastrointestinal lesions, as well as therapeutic procedures, such as foreign body retrieval. In the past, they were primarily used in large institutional settings where specialized personnel could focus on their maintenance. Today, they are becoming increasingly common in general practice. The maintenance of gastrointestinal endoscopes in the veterinary setting involves many challenges, including safe handling, reprocessing, and storage. Meeting these challenges requires well-trained personnel and strict protocols. Reprocessing, which includes cleaning and disinfection, offers the greatest challenge. The complex structure of flexible endoscopes, particularly the long, narrow channels, makes them difficult to clean. Gastrointestinal endoscopes operate in a contaminated environment, exposing them to high levels of organic matter and bacteria. High-level disinfection is necessary for infection control, but liquid germicides available for endoscope disinfection can be toxic to medical personnel and patients.